Shippenberg T S, Emmett-Oglesby M W, Ayesta F J, Herz A
Department of Neuropharmacology, Max-Planck Institute for Psychiatry, Planegg-Martinsried, Federal Republic of Germany.
Psychopharmacology (Berl). 1988;96(1):110-5. doi: 10.1007/BF02431542.
The issue of whether tolerance develops to the motivational effects of opioids was addressed by use of an unbiased place preference conditioning procedure. Administration of the mu-opioid agonists morphine or fentanyl produced dose-related preferences for the drug-associated place in control rats. In contrast, the kappa-opioid agonist, U-69593 produced conditioned place aversions. Non-contingent administration of morphine (5.0 mg/kg/12 h) for 4 days prior to conditioning resulted in tolerance to its reinforcing effects, and cross-tolerance to the effects of fentanyl. No cross-tolerance to the motivational effects of the psychostimulant d-amphetamine or the kappa-opioid agonist U-69593 was observed. Chronic administration of U-69593 prior to conditioning produced tolerance to its aversive effects. This treatment did not, however, modify the reinforcement produced by morphine. These data demonstrate that tolerance develops to both the reinforcing and aversive properties of opioids and suggest that differential cross-tolerance may provide a useful method for determining the pharmacological basis underlying drug-induced motivational effects.
通过使用无偏倚的位置偏好条件反射程序,研究了是否会对阿片类药物的动机效应产生耐受性这一问题。在对照大鼠中,给予μ-阿片受体激动剂吗啡或芬太尼会产生与剂量相关的对药物相关位置的偏好。相比之下,κ-阿片受体激动剂U-69593会产生条件性位置厌恶。在条件反射前4天非连续给予吗啡(5.0毫克/千克/12小时)导致对其强化作用产生耐受性,并对芬太尼的作用产生交叉耐受性。未观察到对精神兴奋剂d-苯丙胺或κ-阿片受体激动剂U-69593的动机效应有交叉耐受性。在条件反射前长期给予U-69593会使其厌恶作用产生耐受性。然而,这种处理并未改变吗啡产生的强化作用。这些数据表明,对阿片类药物的强化和厌恶特性都会产生耐受性,并表明差异交叉耐受性可能为确定药物诱导的动机效应背后的药理学基础提供一种有用的方法。